930 results on '"Disease assessment"'
Search Results
202. The Independent Associations of Physical Activity and Sleep with Cognitive Function in Older Adults
- Author
-
Ryan S. Falck, Jennifer C. Davis, Teresa Liu-Ambrose, and John R. Best
- Subjects
Male ,0301 basic medicine ,Aging ,medicine.medical_specialty ,Physical activity ,Neuropsychological Tests ,Audiology ,Pittsburgh Sleep Quality Index ,Correlation ,03 medical and health sciences ,Cognition ,0302 clinical medicine ,Surveys and Questionnaires ,medicine ,Humans ,Effects of sleep deprivation on cognitive performance ,Exercise ,Aged ,Retrospective Studies ,Aged, 80 and over ,Sleep quality ,business.industry ,General Neuroscience ,General Medicine ,Middle Aged ,Sleep in non-human animals ,Psychiatry and Mental health ,Clinical Psychology ,Cross-Sectional Studies ,030104 developmental biology ,Female ,Independent Living ,Disease assessment ,Geriatrics and Gerontology ,business ,030217 neurology & neurosurgery - Abstract
BACKGROUND Current evidence suggests physical activity (PA) and sleep are important for cognitive health; however, few studies examining the role of PA and sleep for cognitive health have measured these behaviors objectively. OBJECTIVE We cross-sectionally examined whether 1) higher PA is associated with better cognitive performance independently of sleep quality; 2) higher sleep quality is associated with better cognitive performance independently of PA; and 3) whether higher PA is associated with better sleep quality. METHODS We measured PA, subjective sleep quality using the Pittsburgh Sleep Quality Index (PSQI), and objective sleep quality (i.e., fragmentation, efficiency, duration, and latency) using the MotionWatch8© in community-dwelling adults (N = 137; aged 55+). Cognitive function was indexed using the Alzheimer's Disease Assessment Scale-Plus. Correlation analyses were performed to determine relationships between PA, sleep quality, and cognitive function. We then used latent variable modelling to examine the relationships of PA with cognitive function independently of sleep quality, sleep quality with cognitive function independently of PA, and PA with sleep quality. RESULTS We found greater PA was associated with better cognitive performance independently of 1) PSQI (β= -0.03; p
- Published
- 2018
- Full Text
- View/download PDF
203. Selection of maize genotypes resistant to grey leaf spot (Cercospora zeaemaydis)
- Author
-
Basistha Acharya, Homan Regmi, Ram B Khadka, and TR Rijal
- Subjects
Veterinary medicine ,Cercospora ,Genotype ,Sowing ,Leaf spot ,Disease assessment ,Biology ,Plant disease resistance ,biology.organism_classification ,Cercospora zeae-maydis - Abstract
Gray leaf spot (GLS), caused by Cercospora zeae-maydis is an important and destructive foliar disease of maize (Zeae mays) mostly in the mid hills of Nepal. Considering its potential threat to maize production, a total of fourty two and thirty different maize genotypes were evaluated in the year 2012 and 2013 respectively with two replications in observation nursery at Kapurkot, Salyan (1480 masl) for resistance to GLS. Disease assessment was made using 1-5 scale at 15 days interval for three times starting from tasseling stage (65 days after sowing). The results showed that no immune and highly resistant genotypes were found in both the year. Response of 27 out of 42 genotypes of maize were identified as moderately resistant (2-2.5 score) and 15 genotypes showed moderately susceptible (3 score) to GLS during 2012. During 2013 out of 30 genotypes of maize 27 were identified as moderately resistant (1.75-2.5 score) and 3 moderately susceptible (2.75-3 score) to GLS. Among the tested genotypes, BGBYPOP, Rampur SO3FO4, Celaya OOHGYA*HGYB, O7SADVI, Manakamana-3, SO1SIYQ and local were found most promising and moderately resistant to GLS disease during 2012 and SYN312-SR and CML-395/CML-444 during 2013.
- Published
- 2018
- Full Text
- View/download PDF
204. The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review
- Author
-
Manuel Montero-Odasso, Jacqueline K. Kueper, and Mark Speechley
- Subjects
0301 basic medicine ,literature review ,Disease ,Review ,Neuropsychological Tests ,behavioral disciplines and activities ,03 medical and health sciences ,outcome measures ,0302 clinical medicine ,mild cognitive impairment ,Alzheimer Disease ,mental disorders ,medicine ,Dementia ,Humans ,Cognitive Dysfunction ,General Neuroscience ,Outcome measures ,Cognition ,General Medicine ,medicine.disease ,Psychiatry and Mental health ,Clinical Psychology ,030104 developmental biology ,Adas cog ,Scale (social sciences) ,Narrative review ,Disease assessment ,Geriatrics and Gerontology ,ADAS-Cog ,Psychology ,human activities ,030217 neurology & neurosurgery ,Clinical psychology - Abstract
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) was developed in the 1980s to assess the level of cognitive dysfunction in Alzheimer's disease. Advancements in the research field have shifted focus toward pre-dementia populations, and use of the ADAS-Cog has extended into these pre-dementia studies despite concerns about its ability to detect important changes at these milder stages of disease progression. If the ADAS-Cog cannot detect important changes, our understanding of pre-dementia disease progression may be compromised and trials may incorrectly conclude that a novel treatment approach is not beneficial. The purpose of this review was to assess the performance of the ADAS-Cog in pre-dementia populations, and to review all modifications that have been made to the ADAS-Cog to improve its measurement performance in dementia or pre-dementia populations. The contents of this review are based on bibliographic searches of electronic databases to locate all studies using the ADAS-Cog in pre-dementia samples or subsamples, and to locate all modified versions. Citations from relevant articles were also consulted. Overall, our results suggest the original ADAS-Cog is not an optimal outcome measure for pre-dementia studies; however, given the prominence of the ADAS-Cog, care must be taken when considering the use of alternative outcome measures. Thirty-one modified versions of the ADAS-Cog were found. Modification approaches that appear most beneficial include altering scoring methodology or adding tests of memory, executive function, and/or daily functioning. Although modifications improve the performance of the ADAS-Cog, this is at the cost of introducing heterogeneity that may limit between-study comparison.
- Published
- 2018
205. A new framework for collaborative filtering with [formula omitted]-moment-based similarity measure: Algorithm, optimization and application.
- Author
-
Alsaadi, Fuad E., Wang, Zidong, Alharbi, Njud S., Liu, Yurong, and Alotaibi, Naif D.
- Subjects
- *
FRIEDREICH'S ataxia , *RECOMMENDER systems , *ALGORITHMS , *MATHEMATICAL optimization , *PARTICLE swarm optimization - Abstract
In this paper, a general framework of user-based collaborative filtering (CF) is developed with a new p -moment-based similarity measure. The p -moment-based statistics (PMS) of individual rating data are employed to analyze the user rating habit, thereby facilitating the performance improvement of the CF algorithm. On the basis of the PMS, a new yet comprehensive similarity measure is proposed to quantify the distance between two users with focus on both the users' preferences on items and their rating habits. Compared with the traditional ones, our proposed similarity measure is more general with clearer application insights in complicated situations. Furthermore, the weights of different statistics are regarded as adjustable parameters that are determined by utilizing the particle swarm optimization technique so as to achieve good prediction performance. Based on the proposed similarity measure with optimized weights, the neighborhood set consisting of similar users is formed and then the user-based rating prediction is eventually provided. The developed CF algorithm has advantages of high prediction accuracy and wide application potential. Moreover, this CF algorithm is applied on a real-world disease (Friedreich's ataxia) assessment system in order to assist diagnosis for patients with uncertain/missing information. Experimental results demonstrate the validity and efficiency of the proposed algorithm. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
206. Rational oral corticosteroid use in adult severe asthma: A narrative review.
- Author
-
Hew M., Chung L.P., Upham J.W., Bardin P.G., Hew M., Chung L.P., Upham J.W., and Bardin P.G.
- Abstract
OCS play an important role in the management of asthma. However, steroid-related AE are common and represent a leading cause of morbidity. Limited published studies suggest OCS usage varies across countries and recent registry data indicate that at least 25-60% of patients with severe asthma in developed countries may at some stage be prescribed OCS. Recent evidence indicate that many patients do not receive optimal therapy for asthma and are often prescribed maintenance OCS or repeated steroid bursts to treat exacerbations. Given the recent progress in adult severe asthma and new treatment options, judicious appraisal of steroid use is merited. A number of strategies and add-on therapies are now available to treat severe asthma. These include increasing specialist referral for multidisciplinary assessments and implementing OCS-sparing interventions, such as improving guideline adherence and add-on tiotropium and macrolides. Biologics have recently become available for severe asthma; these agents reduce asthma exacerbations and lower OCS exposure. Further research, collaboration and consensus are necessary to develop a structured stewardship approach including realistic OCS-weaning programmes for patients with severe asthma on regular OCS; education and public health campaigns to improve timely access to specialized severe asthma services for treatment optimization; and implementing targeted strategies to identify patients who warrant OCS use using objective biomarker-based strategies.Copyright © 2019 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.
- Published
- 2020
207. Subtyping of primary aldosteronism in the AVIS-2 study: Assessment of selectivity and lateralization.
- Author
-
Battistel M., Shafigullina Z., Quinkler M., Oliveras A., Chang C.-C., Wu V.C., Somloova Z., Maiolino G., Barbiero G., Lenzini L., Quaia E., Pessina A.C., Rossi G.P., Kline G., Rossitto G., Amar L., Azizi M., Riester A., Reincke M., Degenhart C., Widimsky J., Naruse M., Deinum J., Schultzekool L., Kocjan T., Negro A., Rossi E., Tanabe A., Satoh F., Rump L.C., Vonend O., Willenberg H.S., Fuller P., Yang J., Chee N.Y.N., Magill S.B., Battistel M., Shafigullina Z., Quinkler M., Oliveras A., Chang C.-C., Wu V.C., Somloova Z., Maiolino G., Barbiero G., Lenzini L., Quaia E., Pessina A.C., Rossi G.P., Kline G., Rossitto G., Amar L., Azizi M., Riester A., Reincke M., Degenhart C., Widimsky J., Naruse M., Deinum J., Schultzekool L., Kocjan T., Negro A., Rossi E., Tanabe A., Satoh F., Rump L.C., Vonend O., Willenberg H.S., Fuller P., Yang J., Chee N.Y.N., and Magill S.B.
- Abstract
Context: Adrenal venous sampling (AVS) is the key test for subtyping primary aldosteronism (PA), but its interpretation varies widely across referral centers and this can adversely affect the management of PA patients. Objective(s): To investigate in a real-life study the rate of bilateral success and identification of unilateral aldosteronism and their impact on blood pressure outcomes in PA subtyped by AVS. Design and settings: In a retrospective analysis of the largest international registry of individual AVS data (AVIS-2 study), we investigated how different cut-off values of the selectivity index (SI) and lateralization index (LI) affected rate of bilateral success, identification of unilateral aldosteronism, and blood pressure outcomes. Result(s): AVIS-2 recruited 1625 individual AVS studies performed between 2000 and 2015 in 19 tertiary referral centers. Under unstimulated conditions, the rate of biochemically confirmed bilateral AVS success progressively decreased with increasing SI cut-offs; furthermore, with currently used LI cut-offs, the rate of identified unilateral PA leading to adrenalectomy was as low as <25%. A within-patient pairwise comparison of 402 AVS performed both under unstimulated and cosyntropin-stimulated conditions showed that cosyntropin increased the confirmed rate of bilateral selectivity for SI cut-offs >= 2.0, but reduced lateralization rates (P < 0.001). Post-adrenalectomy outcomes were not improved by use of cosyntropin or more restrictive diagnostic criteria. Conclusion(s): Commonly used SI and LI cut-offs are associated with disappointingly low rates of biochemically defined AVS success and identified unilateral PA. Evidence-based protocols entailing less restrictive interpretative cut-offs might optimize the clinical use of this costly and invasive test.Copyright © Endocrine Society 2019. All rights reserved.
- Published
- 2020
208. The lived experience of chronic pain and dyskinesia in children and adolescents with cerebral palsy.
- Author
-
White J.H., McKinnon C.T., Morgan P.E., Harvey A.R., Fahey M.C., Clancy C.H., Antolovich G.C., White J.H., McKinnon C.T., Morgan P.E., Harvey A.R., Fahey M.C., Clancy C.H., and Antolovich G.C.
- Abstract
Background: To explore the lived experience of chronic pain and dyskinesia in children and adolescents with cerebral palsy. Method(s): A convergent parallel mixed methods design was undertaken. First, a quantitative cross-sectional study of participants able to self-report their quality of life was undertaken. This study characterised pain chronicity, intensity, body locations, and quality of life. Second, semi-structured interviews were undertaken with a subset of children and adolescents experiencing chronic pain. Result(s): Twenty-five children and adolescents took part in the cross-sectional study, 23 of whom experienced chronic pain and 13 of moderate intensity. Pain was often located in multiple bodily regions (6/21), with no trends in quality of life outcomes detected. Eight participated in semi-structured interviews, which identified three key themes including 'lives embedded with dyskinesia', 'real world challenges of chronic pain', and 'still learning strategies to manage their pain and dyskinesia'. Conclusion(s): A high proportion of children and adolescents with cerebral palsy and dyskinesia who were able to self-report experienced chronic pain. The physical and emotional impacts of living with chronic pain and dyskinesia existed along a spectrum, from those with lesser to greater extent of their impacts. Children and adolescents may benefit from targeted chronic pain education and management within bio-psychosocial models.Copyright © 2020 The Author(s).
- Published
- 2020
209. Survival of patients with ruptured and non-ruptured hepatocellular carcinoma.
- Author
-
Nicoll A., Sood S., Lubel J., Dev A., Kemp W.W., Bell S.J., Tan N.P., Majeed A., Roberts S.K., Gow P.J., Hey P., Mah X., Goodwin M., Nicoll A., Sood S., Lubel J., Dev A., Kemp W.W., Bell S.J., Tan N.P., Majeed A., Roberts S.K., Gow P.J., Hey P., Mah X., and Goodwin M.
- Published
- 2020
210. Epidemiology of cashew anthracnose (Colletotrichum gloeosporioides Penz.) in Mozambique.
- Author
-
Uaciquete, A., Korsten, L., and Van der Waals, J.E.
- Subjects
PLANT epidemiology ,ANTHRACNOSE ,CASHEW nuts ,COLLETOTRICHUM gloeosporioides ,EXPONENTIAL functions ,POLYMERASE chain reaction - Abstract
Abstract: Anthracnose of cashew (Anacardium occidentale) was studies on various genotypes and locations in Mozambique. Colletotrichum gloeosporioides was identified as the anthracnose causal agent using polymerase chain reaction. The relationships between incidence and severity of anthracnose on cashew genotypes were statistically analyzed by regression. Anthracnose leaf incidence, which is practically easy to evaluate, was consistently associated with leaf severity, and their relationships can be estimated using the restricted exponential function across locations, crop seasons, genotype and fungicide trials. Pooled data enabled estimation of initial incidence of 1.43% with percentage variance accounting for 83.2 and standard error of 8.3. By computing incidence data into the summary equation, 24 changes of 0, 1, 5, 10 and 40%, resulted in changes of severity estimates of 0.01, 0.05, 0.10, 0.50 and 1.00%, respectively. The maximum disease incidence was estimated as 80% when the severity reached only 5%. Increase in severity was observed afterward, approached a maximum of 25% when leaf detachment is observed. The use of incidence data for epidemic comparisons, genotype and fungicide evaluation in cashew orchards is recommended. Anthracnose incidence on leaves however, could not predict incidence on nuts. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
211. Development and validation of a standard area diagram set to assess blast severity on wheat leaves.
- Author
-
Rios, Jonas, Debona, Daniel, Duarte, Henrique, and Rodrigues, Fabrício
- Abstract
This study aimed to develop and validate a standard area diagram set (SADS) to quantify the severity of blast, caused by Pyricularia oryzae, on wheat leaves. The SADs has ten levels: 0.1, 1, 5, 10, 22, 32, 42, 52, 62 and 72 % blast severity. To validate the SADs, 12 inexperienced raters estimated disease severity on 50 images of leaves from cultivars BR-18 (susceptible) and BRS-229 (partially resistant). Blast severity was first estimated without the use of the SADs on 50 leaves with a range of blast severity. The same raters evaluated the same 50 leaves using the SADs as an aid. The SADs improved accuracy (coefficient of bias, C = 0.88 and 0.99, without and with SADs, respectively) and agreement (Lin's concordance correlation coefficient, ρ = 0.84 and 0.96 without and with SADs, respectively) of the estimates of severity. The absolute error was (-) 52 % without the SADs and (-) 24 % when using SADs as an aid. Severity estimates were more reliable when using SADs (R = 0.87 unaided and R = 0.92 with SAD). The SADs proposed in this study will improve accuracy and reliability of estimates of blast severity on wheat leaves. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
212. Advances in the diagnosis, assessment and outcome of Takayasu's arteritis.
- Author
-
Alibaz-Oner, Fatma, Aydin, Sibel, and Direskeneli, Haner
- Subjects
- *
TAKAYASU arteritis , *RARE diseases , *VASCULITIS , *ARTERIAL stenosis , *HEALTH outcome assessment , *DIAGNOSIS , *THERAPEUTICS ,PULMONARY artery diseases - Abstract
Takayasu's arteritis (TAK) is a rare, chronic large-vessel vasculitis (LVV) that predominantly affects aorta, its major branches, and the pulmonary arteries. Segmental stenosis, occlusion, dilatation, or aneurysm formation may occur in the vessel wall during the course of the disease. The vascular involvement can be shown with different imaging modalities to make the diagnosis of TAK. Conventional angiography, the gold standard method for initial diagnosis, seems to be replaced with the new imaging modalities such as magnetic resonance angiography (MRA) and F-fluorodeoxyglucose positron emission tomography (FDG-PET) in recent years. The data coming from the new studies support that MRA and FDG-PET are also promising for the assessment of disease activity. Prognosis is possibly getting better with lower mortality in recent years; however, it is difficult to assess the widely different vascular intervention rates among the clinical series. Leflunomide, TNF-α antagonists, and tocilizumab are new options in patients resistant to conventional therapies. There is a clear need to develop a validated set of outcome measures for use in clinical trials of TAK. The OMERACT Vasculitis Working Group has taken on this task and aims to develop a core set of outcomes for LVV. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
213. Development and validation of standard area diagrams to aid assessment of pecan scab symptoms on fruit.
- Author
-
Yadav, N. V. S., de Vos, S. M., Bock, C. H., and Wood, B. W.
- Subjects
- *
FUSICLADIUM , *RELIABILITY (Personality trait) , *ACCURACY , *STATISTICAL correlation - Abstract
Pecan scab ( Fusicladium effusum) causes losses of pecan nutmeat yield and quality in the southeastern United States. Disease assessment relies on visual rating, which can be inaccurate and imprecise, with poor inter-rater reliability. A standard area diagram (SAD) set for pecan scab on fruit valves was developed. A set of 40 images of diseased fruit valves with known severity was assessed twice by 23 raters. The first assessment was conducted without SADs, and the second assessment was made using the SADs as an aid. SADs improved rater accuracy (correction factor, Cb = 0·86 and 0·97, without and with SADs, respectively) and agreement (Lin's concordance correlation coefficient, ρc = 0·79 and 0·89 without and with SADs, respectively) with true values. SADs improved inter-rater reliability (intra-class correlation coefficient, ρ = 0·77 and 0·96 without and with SADs, respectively). The least accurate and precise raters without SADs improved more using SADs compared to the most accurate and precise raters. Experienced raters had significantly higher accuracy and precision compared to inexperienced raters, but only when unaided by the SAD set. There was no significant difference in time to assess images without SADs, but experienced raters using SADs were faster compared to inexperienced raters. There was a slight tendency for faster raters to assess more slowly, and slower raters to assess faster when using SADs. SADs improve rater estimates of pecan scab severity on fruit, and this SAD set should be useful for assessment where greater precision, accuracy and inter-rater reliability are required. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
214. Rapid assessment of resistance of tissue-cultured water yam ( Dioscorea alata ) and white guinea yam ( Dioscorea rotundata ) to anthracnose ( Colletotrichum gloeosporioides Penz.).
- Author
-
Popoola, Akinola Rasheed, Adedibu, Bosola Okuyinka, and Ganiyu, Sikiru Adebare
- Subjects
- *
YAM anthracnose , *TISSUE culture , *PLANT species , *TILLAGE - Abstract
Yam anthracnose is caused by the pathogenColletotrichum gloeosporioidesPenz. and has been identified as the most important biotic constraint to yam production worldwide. Rapid assessment of the disease is vital to its effective diagnosis and management. In this study, tissue-cultured yam plantlets of five lines ofDioscorea alataand nine ofD. rotundatawere rapidly assessed for their reactions to two isolates of yam anthracnose. The plantlets, obtained from meristem of the nodal cuttings, were grown for 8 weeks on Murashige and Skoog (MS) basal medium, acclimatised for 3 weeks, hardened for an additional 3 weeks, arranged in screen house in completely randomised design and sprayed with spore inocula prepared from 7 day-old culture of the two strains ofColletotrichum gloeosporioidiesPenz. The relative resistance of the differentDioscoreaspp. was evaluated using three disease indices – severity at seventh day after inoculation, SD7; area under disease progress curve, AUDPC; and disease severity rate, Rd. A modified rank-sum classification method put TDa 1425 and TDr 2040, with rank sum of 2.0 each, as resistant. TDr 2121, TDr 2287 and TDr 2048 were susceptible with rank sum of 27.50, 25.50 and 24.50, respectively.Dioscorea alataTDa 1425 andDioscorea rotundataTDr 2040 were recommended in areas endemic with yam anthracnose, and also as parent lines while breeding for resistance to anthracnose. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
- Full Text
- View/download PDF
215. Visual and Electronic Evaluations of Detached Strawberry Leaves Inoculated with Colletotrichum Species.
- Author
-
Miller-Butler, M.A., Curry, K.J., Kreiser, B.R., and Smith, B.J.
- Subjects
- *
STRAWBERRIES , *LEAF diseases & pests , *COLLETOTRICHUM , *ANTHRACNOSE , *PLANT germplasm , *GLOEOSPORIUM , *IMAGE analysis - Abstract
Inoculation of detached strawberry leaves with Colletotrichum species may provide an accurate, rapid, non-destructive method of identifying anthracnose resistant germplasm. Two assessments of anthracnose disease severity were compared on detached strawberry leaves inoculated with Colletotrichum fragariae and C. gloeosporioides: a quantitative assessment made via computer-based image analysis and a visual assessment made by two independent raters. The image analysis provided a precise measurement of percent lesion area of infected leaves. There was a strong positive correlation between percent lesion area and the visual disease scores of the raters. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
216. Reaction of Selected Apple Cultivars to Wilt Pathogen Verticillium dahliae.
- Author
-
Karajeh, Muwaffaq R. and Owais, Saed J.
- Subjects
APPLE diseases & pests ,WILT diseases ,VERTICILLIUM dahliae ,GREENHOUSE plants ,SEEDLINGS ,OLIVE diseases & pests - Abstract
The reaction of five apple cultivars to olive wilt caused by Verticillium dahliae Kleb was evaluated. Five apple cultivars (Royal Gala, Delicious Anabri, Double Red, Golden Delicious, Granny Smith) and one olive cultivar (Nabali Mohassan) were inoculated with V. dahliae and grown under partially controlled greenhouse conditions. Typical symptoms of the disease were developed on the inoculated olive seedlings. However, all tested apple cultivars did not show the typical symptoms of Verticillium wilt except cv. Delicious Anbari, which showed 8.31% disease severity. The average percentage of disease severity was 61.2% in Nabali Mohassan. The pathogen was positively re-isolated from the inoculated seedlings of cvs Nabali Mohassan and Delicious Anbari after 12 months from the inoculation date. Results indicate that an apple plantation to replace dead or severely diseased olive trees infested with Verticillium wilt is an appropriate low-cost and environmentally sound IPM alternative approach to control Verticillium wilt. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
217. Effects of temperature on infection and subsequent development of clubroot under controlled conditions.
- Author
-
Gossen, B. D., Adhikari, K. K. C., and McDonald, M. R.
- Subjects
- *
CLUBROOT , *RUTABAGA , *EFFECT of temperature on plants ,FUNGAL diseases of plants & climate ,SEEDLING diseases & pests - Abstract
Controlled-environment studies were conducted on two Brassica crops (canola, Brassica napus; and Shanghai pak choi, B. rapa subsp. chinensis var. communis) to examine the effects of temperature on infection and subsequent development of clubroot caused by Plasmodiophora brassicae. In the first experiment, canola seedlings were grown in infested soil for 3 weeks at 14-26°C to assess the impact on primary and secondary infection and transferred to 20°C for 3 weeks to assess symptom development under uniform conditions, or started at 20°C for 3 weeks and then placed at the treatment temperatures for the final 3 weeks to assess the impact of temperature on symptom development. A second experiment examined a wider range of temperatures (10-30°C). Similar experiments were also conducted on Shanghai pak choi. The studies demonstrated that clubroot severity was affected by temperature during both infection and vegetative development of the crop. Both early and late in crop development, little or no clubroot developed at temperatures at or below 17°C, and development was slower above 26°C than at 23-26°C for both crops throughout the study. In canola, the high levels of inoculum used in the study resulted in a high incidence of clubroot irrespective of temperature, but in pak choi incidence showed the same pattern as severity. This is the first study to demonstrate under controlled conditions that temperature during vegetative growth of the crop affects symptom development of clubroot. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
218. Validation study of the Alzheimer’s disease assessment scale–cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer’s disease
- Author
-
Diana Duro, Joana Nogueira, Isabel Santana, Sandra Freitas, and Jorge Almeida
- Subjects
Male ,Psychometrics ,Disease ,Neuropsychological Tests ,Sensitivity and Specificity ,03 medical and health sciences ,0302 clinical medicine ,Arts and Humanities (miscellaneous) ,Alzheimer Disease ,Developmental and Educational Psychology ,medicine ,Humans ,Dementia ,Cognitive Dysfunction ,Translations ,Effects of sleep deprivation on cognitive performance ,Neuropsychological assessment ,Cognitive impairment ,Aged ,Language ,Aged, 80 and over ,Portugal ,medicine.diagnostic_test ,Cognition ,Middle Aged ,medicine.disease ,030227 psychiatry ,Psychiatry and Mental health ,Clinical Psychology ,Neuropsychology and Physiological Psychology ,Adas cog ,Case-Control Studies ,Female ,Disease assessment ,Psychology ,030217 neurology & neurosurgery ,Clinical psychology - Abstract
The Alzheimer's disease assessment scale-Cognitive Subscale (ADAS-Cog) is a battery to assess cognitive performance in Alzheimer's disease (AD) and was developed according to the core characteristics of cognitive decline in AD: memory, language, praxis, constructive ability, and orientation. The aim of this study was to explore the diagnostic accuracy and discriminative capacity of the ADAS-Cog for Mild Cognitive Impairment (MCI) and AD, using cut-off points for the Portuguese population.The European Portuguese version of the ADAS-Cog was administrated to 650 participants, divided into a control group (n = 210), an MCI group (n = 240), and an AD group (n = 200). The clinical groups fulfilled standard international diagnostic criteria. Controls were healthy cognitive participants actively integrated in the community. The neuropsychological assessment protocol included the ADAS-Cog, the Mini Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), and the Adults and Older Adults Functional Assessment Inventory (IAFAI).The ADAS-Cog revealed good psychometric indicators, and the total scores were significantly different between the three groups (p .001: Control MCI AD). The optimal cut-off points established were: MCI 9 points (AUC = .835; sensitivity = 58% and specificity = 91%) and AD 12 points (AUC = .996; sensitivity = 94% and specificity = 98%).Our findings confirmed the capacity of the ADAS-Cog total score to identify cognitive impairment in AD patients, with poor sensitivity for MCI, in a Portuguese cohort.
- Published
- 2018
- Full Text
- View/download PDF
219. Alzheimer’s Disease Assessment Scale - Cognitive Subscale (ADAS-Cog): Normative Data for the Portuguese Population
- Author
-
Miguel Tábuas-Pereira, Diana Duro, Jorge Almeida, Joana Nogueira, Isabel Santana, Manuela Guerreiro, Sandra Freitas, Isabel Santana, Direção Geral de Saúde, Sandra Freitas, Investigador FCT (IF/01325/2015), Jorge Almeida, FCT COMPETE grants PTDC/MHC-PCN/0522/2014, and PTDC/MHC-PCN/6805/2014, Isabel Santana - grant of the Direção-Geral de Saúde, Sandra Freitas - supported by Foundation for Science and Technology and program Investigador FCT (IF/01325/2015), and Jorge Almeida - supported by BIAL Foundation project 2014/495.
- Subjects
050103 clinical psychology ,Disfunção Cognitiva ,Doença de Alzheimer ,Inquéritos e Questionários ,Portugal ,Testes Neuropsicológicos ,Traduções ,05 social sciences ,Alzheimer Disease ,Cognitive Dysfunction ,Neuropsychological Tests ,Surveys and Questionnaires ,Translations ,General Medicine ,03 medical and health sciences ,0302 clinical medicine ,Adas cog ,0501 psychology and cognitive sciences ,Disease assessment ,Portuguese population ,Psychology ,Humanities ,030217 neurology & neurosurgery - Abstract
Introdução: A Escala de Avaliação da Doença de Alzheimer – subescala cognitiva (ADAS-Cog) é uma bateria neuropsicológica breve desenvolvida para caracterizar o desempenho cognitivo de doentes com doença de Alzheimer. Avalia as funções tipicamente mais comprometidas na doença de Alzheimer considerando os seguintes domínios cognitivos: memória, orientação, linguagem, praxia e capacidade construtiva. A deteção precoce das alterações cognitivas assim como a sua monitorização são fundamentais para a prática em ambos os contextos clínico e de investigação. O presente estudo tem como objetivos analisar as propriedades psicométricas da versão portuguesa da Escala de Avaliação da Doença de Alzheimer – subescala cognitiva e estabelecer dados normativos para a população portuguesa.Material e Métodos: A versão portuguesa da Escala de Avaliação da Doença de Alzheimer – subescala foi administrada a 223 participantes cognitivamente saudáveis. Todos os participantes foram avaliados com os seguintes instrumentos: Mini-Mental State Examination, Montreal Cognitive Assessment e Inventário de Avaliação Funcional de Adultos e Idosos. Considerou-se como critério para a inclusão no estudo obter um desempenho normal nestas três provas.Resultados: A Escala de Avaliação da Doença de Alzheimer – subescala revelou boas propriedades psicométricas quando utilizada na população portuguesa. A idade demonstrou ser o principal preditor do desempenho na Escala de Avaliação da Doença de Alzheimer – subescala (R2 = 0,123), tendo a escolaridade menor influência (R2 = 0,027). Em conjunto, estas variáveis sociodemográficas explicaram 14,4% da variância na pontuação total da Escala de Avaliação da Doença de Alzheimer – subescala, sendo ambas consideradas na estratificação dos dados normativos para a população portuguesa.Conclusão: A pontuação total média na Escala de Avaliação da Doença de Alzheimer – subescala foi de 6 pontos. Os dados normativos foram estabelecidos de acordo com a idade e escolaridade, sendo estas variáveis sociodemográficas as que mais contribuíram para a predição do desempenho na Escala de Avaliação da Doença de Alzheimer – subescala, explicando 14,4% da variância. Os dados normativos são de extrema importância para o uso adequado desta bateria em Portugal.
- Published
- 2018
- Full Text
- View/download PDF
220. The conceptual relevance of assessment measures in patients with mild/mild‐moderate Alzheimer's disease
- Author
-
Myrlene Sanon, Ann Hartry, Richard G. Stefanacci, Sarah Knight, Natalie V. J. Aldhouse, and T. Al-Zubeidi
- Subjects
Disease ,lcsh:Geriatrics ,Neuropsychiatry ,Outcome measures ,Conceptual relevance ,lcsh:RC346-429 ,Disease activity ,03 medical and health sciences ,0302 clinical medicine ,Patient experience ,Qualitative interviews ,Medicine ,Daily living ,Relevance (information retrieval) ,In patient ,Mild/mild‐moderate Alzheimer's disease ,030212 general & internal medicine ,lcsh:Neurology. Diseases of the nervous system ,business.industry ,Quantitative survey ,Patient-reported outcome (PRO) ,Mild/mild-moderate Alzheimer's disease ,lcsh:RC952-954.6 ,Psychiatry and Mental health ,Cognitive & Behavioral Assessment ,Patient‐reported outcome (PRO) ,Neurology (clinical) ,Disease assessment ,business ,030217 neurology & neurosurgery ,Clinical psychology - Abstract
Introduction This study aims to evaluate the conceptual relevance of four measures of disease activity in patients with mild/mild-moderate Alzheimer's disease (AD): (1) the Alzheimer's Disease Assessment Scale–Cognitive Subscale; (2) the Alzheimer's Disease Cooperative Study–Activities of Daily Living Inventory; (3) the Neuropsychiatry Inventory; and (4) the Dependence Scale. Methods A conceptual model depicting patient experience of mild AD was developed via literature review; concepts were compared with the items of the four measures. Relevance of the concepts included in the four measures was evaluated by patients with mild AD in a survey and follow-up interviews. Results The four measures assessed few of the symptoms/impacts of mild AD identified within the literature. Measured items addressing emotional impacts were deemed most relevant by participants but were included in the measures only superficially. Discussion The four assessment measures do not appear to capture the concepts most relevant to/important to patients with mild/mild-moderate AD., Highlights • Many impacts associated with mild Alzheimer's disease were reported by patients. • The included outcome measures assessed did not provide high conceptual coverage. • These four measures appeared more suitable for more severe Alzheimer's disease. • Completion of patient reported outcomes should be possible in this patient population. • These may be currently used in addition to clinician- and observer-reported outcomes.
- Published
- 2018
- Full Text
- View/download PDF
221. Randomized, controlled, proof‐of‐concept trial of MK‐7622 in Alzheimer's disease
- Author
-
David Michelson, Martin R. Farlow, Jeffrey L Cummings, Linda Snow-Adami, Jerry Li, Christopher Assaid, Kerry Budd McMahon, Tiffini Voss, Michael F. Egan, Heather Leibensperger, and Samar Froman
- Subjects
0301 basic medicine ,medicine.medical_specialty ,medicine.drug_class ,Allosteric modulator ,Disease ,Placebo ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Muscarinic ,medicine ,Adverse effect ,Cholinergic ,MK-7622 ,business.industry ,Cognition ,Featured Article ,Alzheimer's disease ,Confidence interval ,3. Good health ,Clinical trial ,Psychiatry and Mental health ,030104 developmental biology ,Acetylcholinesterase inhibitor ,Neurology (clinical) ,Disease assessment ,business ,030217 neurology & neurosurgery - Abstract
Introduction We evaluated the selective M1 muscarinic positive allosteric modulator, MK-7622, as adjunctive cognitive enhancing therapy in individuals with Alzheimer's disease. Methods A randomized, double-blind, proof-of-concept trial was performed. Participants with mild-to-moderate Alzheimer's disease, being treated with an acetylcholinesterase inhibitor, were randomized 1:1 to 45 mg of MK-7622 or placebo for 24 weeks. Endpoints included the mean change from baseline in Alzheimer's Disease Assessment Scale–Cognitive Subscale (ADAS-Cog11) at 12 weeks and Alzheimer's Disease Cooperative Study–Activities of Daily Living Inventory at 24 weeks. Results Two hundred forty participants were randomized. The trial was stopped for futility after meeting prospectively defined stopping criteria. MK-7622 did not improve cognition at 12 weeks (group difference in ADAS-Cog11: 0.18 [95% confidence interval: −1.0 to 1.3]) or function at 24 weeks (group difference in Alzheimer's Disease Cooperative Study–Activities of Daily Living Inventory: 0.06 [95% confidence interval: −2.4 to 2.5]). More participants taking MK-7622 discontinued study medication because of adverse events than those taking placebo (16% vs 6%) and who experienced cholinergically related adverse events (21% vs 8%). Discussion MK-7622 (45 mg) does not improve cognition or function when used as adjunctive therapy in mild-to-moderate Alzheimer's disease., Highlights • MK-7622 is a positive allosteric modulator of the M1 receptor. • MK-7622 did not improve cognition or function in Alzheimer's disease patients. • MK-7622 increased cholinergically related side effects in Alzheimer's disease patients. • M1 positive allosteric modulation is not useful for treating Alzheimer's disease.
- Published
- 2018
- Full Text
- View/download PDF
222. Estimating deoxynivalenol contents of wheat samples containing different levels of Fusarium-damaged kernels by diffuse reflectance spectrometry and partial least square regression
- Author
-
Beyer, Marco, Pogoda, Friederike, Ronellenfitsch, Franz K., Hoffmann, Lucien, and Udelhoven, Thomas
- Subjects
- *
LEAST squares , *REGRESSION analysis , *FUSARIUM diseases of plants , *WHEAT diseases & pests , *FOOD quality , *SPECTROMETRY , *MYCOTOXINS , *HIGH performance liquid chromatography - Abstract
Abstract: Fusarium head blight is a fungal disease causing yield losses and mycotoxin contamination in wheat and other cereals. Wheat kernels (cultivar Ritmo) were sampled in 2001, 2002, 2003, and 2006 and Fusarium-damaged kernels were separated from sound grain based on visual assessment. Subsequently, grain lots containing 0, 20, 40, 60, 80, and 100% of damaged kernels were compiled. Each lot was split and the spectrometric reflectance (wavelengths 350–2500nm) was measured using subgroup one, while the concentration of the mycotoxin deoxynivalenol (DON) was determined by high-performance liquid chromatography in subgroup two. DON concentrations in batches classified as sound were not significantly different from 0. Estimating DON contents from the percentage of Fusarium-damaged kernels was impeded by vast variability, resulting in a coefficient of determination of 0.49. Using spectrometric data subjected to partial least square regression allowed estimating DON contents with higher accuracy, in particular at elevated percentages of damaged kernels. The coefficient of determination was 0.84 for the relationship between DON contents estimated based on spectrometric data and the DON contents measured. The intercept of a regression line fitted through a plot of estimated versus measured DON contents was 0.89±3.61mg/kg. Since intercept+standard error was larger than the actual legal limit (1.25mg DON per kg dry grain in the European Union), the spectrometric procedure was still not precise enough to allow a reliable separation of grain samples with DON contents below 1.25mg/kg from samples with DON contents above the limit. However, spectrometric data also allowed estimating the DON content of the average damaged kernel within a given lot composed of sound and damaged kernels, which is probably the reason for the reduction of the fraction of unexplained variance by 35% compared to the visual approach and illustrates that spectrometric approaches can make a contribution to reducing DON contents of wheat grain. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
223. Analysis of leaf appearance, leaf death and phoma leaf spot, caused by Leptosphaeria maculans, on oilseed rape ( Brassica napus) cultivars.
- Author
-
Powers, S. J., Pirie, E. J., Latunde-Dada, A. O., and Fitt, B. D. L.
- Subjects
- *
LEAF spots , *PHOMA , *LEPTOSPHAERIA , *RAPE (Plant) , *CULTIVARS - Abstract
Development of phoma leaf spot (caused by Leptosphaeria maculans) on winter oilseed rape (canola, Brassica napus) was assessed in two experiments at Rothamsted in successive years (2003–04 and 2004–05 growing seasons). Both experiments compared oilseed rape cultivars Eurol, Darmor, Canberra and Lipton, which differ in their resistance to L. maculans. Data were analysed to describe disease development in terms of increasing numbers of leaves affected over thermal time from sowing. The cultivars showed similar patterns of leaf spot development in the 2003–04 experiment when inoculum concentration was relatively low (up to 133 ascospores m−3 air), Darmor developing 5.3 diseased leaves per plant by 5 May 2004, Canberra 6.6, Eurol 6.8 and Lipton 7.5. Inoculum concentration was up to sevenfold greater in 2004–05, with Eurol and Darmor developing 2.4 diseased leaves per plant by 16 February 2005, whereas Lipton and Canberra developed 2.8 and 3.0 diseased leaves, respectively. Based on three defined periods of crop development, a piece-wise linear statistical model was applied to the progress of the leaf spot disease (cumulative diseased leaves) in relation to appearance (‘birth’) and death of leaves for individual plants of each cultivar. Estimates of the thermal time from sowing until appearance of the first leaf or death of the first leaf, the rate of increase in number of diseased leaves and the area under the disease progress line (AUDPL) for the first time period were made. In 2004–05, Canberra (1025 leaves ×°C days) and Lipton (879) had greater AUDPL values than Eurol (427) and Darmor (598). For Darmor and Lipton, the severity of leaf spotting could be related to the severity of stem canker at harvest. Eurol had less leaf spotting but severe stem canker, whereas Canberra had more leaf spotting but less severe canker. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
224. Nitrogen and water management can limit premature ripening of sunflower induced by Phoma macdonaldii
- Author
-
Seassau, C., Dechamp-Guillaume, G., Mestries, E., and Debaeke, P.
- Subjects
- *
RIPENING of crops , *COMMON sunflower , *CROPS , *NITROGEN , *PLANT diseases , *CROP management , *PLANT fertilization , *FIELD research - Abstract
Abstract: Premature ripening (PR) is one of the most important diseases of sunflower in France since the 90s. Previous results indicated that girdling canker of the stem base, caused by Phoma macdonaldii was its primary cause but elucidation of critical environmental factors involved is crucial for better control of the disease. A field study was conducted in three contrasting cropping seasons (2006–2008) and investigated the effect of N fertilization (0, 75 and 150kgNha−1) and water regime (rainfed, irrigated) on two cultivars with artificial inoculation (AI) and natural infection (NI). Disease assessment was recorded weekly to calculate the area under disease progress curve (AUDPC) and the final percentage of PR plants. Data showed that high levels of N fertilization led to significantly (P <0.05) more PR than non-fertilization. Water deficit conditions were significantly (P <0.05) involved in disease severity, and AUDPC and PR were increased when dry conditions were associated with high N supply. This was true for two cultivars which differed in their susceptibility to the disease but cv. Heliasol RM was significantly (P <0.05) more affected than cv. Melody, partially resistant to PR. Despite contrasting weather patterns, these results demonstrated a clear role of crop management and environmental conditions on the incidence and severity of stem base attacks responsible for the PR syndrome. These findings suggest that sunflower crop husbandry should be adapted to minimize premature ripening induced by P. macdonaldii. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
225. The Prognostic Value of Early Measurable Residual Disease Assessment in Patients with Acute Myeloid Leukemia Treated with Intensive Chemotherapy - Preliminary Results of Polish Adult Leukemia Group PALG-AML1/2016 Study
- Author
-
Katarzyna Dulik, Agnieszka Wierzbowska, Damian Mikulski, Janusz Hałka, Krzysztof Wozniczka, Agnieszka Pluta, Tomasz Wróbel, Malgorzata Razny, Nuria Mencia-Trinchant, Andrzej Szczepaniak, Nicole M. Cruz, Agata Obara, Gail J. Roboz, Pinkal Desai, Sebastian Giebel, Michal Soin, Magdalena Dutka, Marta Sobas, Ellen K. Ritchie, Michael B. Samuel, Ewelina Perdas, Marek Hus, Justin D. Kaner, Maria Bieniaszewska, Lidia Gil, Wojciech Fendler, Piotr Stelmach, Edyta Cichocka, Anna Czyż, Marta Antonina Libura, Magdalena Czemerska, Elżbieta Patkowska, Monica L. Guzman, Jolanta Wozniak, Sangmin Lee, Agnieszka Kopacz, Tomasz Gromek, Jerzy Holowiecki, Anna Kopińska, Karol Wojcik, and Grzegorz Helbig
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Immunology ,Myeloid leukemia ,Cell Biology ,Hematology ,Intensive chemotherapy ,medicine.disease ,Biochemistry ,Leukemia ,hemic and lymphatic diseases ,Internal medicine ,Medicine ,In patient ,Disease assessment ,business ,Value (mathematics) - Abstract
Background: Measurable residual disease (MRD) is an important biomarker in acute myeloid leukemia (AML). Among patients who achieve remission after standard chemotherapy, detection of MRD (MRD+) after two cycles of intensive chemotherapy, at the end of consolidation and before allogeneic stem cell transplantation (alloHSCT) is a strong prognostic factor for relapse and shorter overall survival (OS) (Short NJ, JAMA Oncol. 2020). The optimal time-points to asses MRD, and MRD cut-offs as well as whether eliminating of MRD due to further chemotherapy improves an outcome still remain open questions. PALG-AML1/2016 study aims to compare the safety and efficacy of two commonly used induction and salvage regimens in AML (NCT03257241). This is also the first international randomized trial in AML induction to prospectively evaluate the impact of MRD on overall survival, using multi-modality testing (flow-cytometry, FC; next-generation sequencing, NGS) of serial samples. Study Design: In this study, 582 adult patients with newly-diagnosed AML will be randomized to DA-90 or DAC induction. Patients with complete remission (CR) or CR with incomplete hematologic recovery (CRi) receive further post-remission therapy adjusted to predefined risk group. The serial samples for multimodal MRD evaluation are collected at D14 (MRD-1), at time of CR/CRi after single or two induction cycles (MRD-2), and after each consolidation cycle (MRD-3, -4, -5). Material and Methods. The aim of this preliminary analysis was to evaluate the prognostic value of bone marrow assessment at D14 both cytological and by FC (MRD-1) as well as the kinetics of MRD during post-remission treatment. Multivariable logistic regression models were developed with significant variables from univariate analyses, including MRD and blast count. The predictive power of the MRD level and blasts percentage at D14 was evaluated by receiver operating characteristics (ROC) and area under the curve (AUC) analysis to determine the ability of the biomarkers to accurately predict response to the induction treatment. Results: The study group consisted of 284 patients (mean age: 47.1 ± 10.9) recruited until the end of May 2021. MRD-1 by FC was reported in 225 patients. CR and CRi either after single or double induction were achieved in 175 (61.6%) and 48 (16.9%) patients, respectively leading to an overall CR/CRi rate 78.5%. In univariate analyses, the factors significantly associated with achieving CR/CRi were: ELN high-risk group (OR 0.12, 95% CI: 0.05-0.33, p MRD-3 at the end of consolidation 1 was reported in 182 patients: MRD+ in 99 (54.4%) and MRD- in 83 (45.6%) patients. Results of MRD-4 at the end of consolidation 2 were available in 114 patients with 49 (43.0%) being MRD+ and 65 (57.0%) MRD-. Fifty-eight patients (35 MRD-2+ and 23 MRD-2-) were evaluated for MRD kinetics from the end of induction until the end of consolidation 3. Conversion rate from MRD- to MRD+ was 13% (n=3) and from MRD+ to MRD- 34%(n=12), respectively (p=0.038). Conclusions: Our preliminary results suggest that flow cytometric bone marrow assessment on D14 has a predictive value for CR/CRi achievement and a potential prognostic utility for overall survival. The kinetics of MRD during consolidation requires further studies to better evaluate its prognostic significance. References Short NJ, JAMA Oncol. 2020; Zhou S, Fu C, et al. Association of Measurable Residual Disease with Survival Outcomes in Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-analysis. 6(12):1890-1899. Disclosures Wierzbowska: Celgene/BMS: Consultancy; Jazz: Research Funding; Novartis: Consultancy; Abbvie: Consultancy; Astellas: Consultancy; Janssen: Consultancy. Libura: Novartis: Consultancy, Research Funding. Giebel: Pfizer: Consultancy, Honoraria, Speakers Bureau; Janssen: Honoraria, Speakers Bureau; Amgen: Consultancy, Honoraria, Speakers Bureau; Novartis: Consultancy, Honoraria, Speakers Bureau. Czemerska: Novartis: Honoraria; Takeda: Honoraria. Sobas: Novartis: Consultancy, Honoraria; Celgene: Consultancy, Honoraria. Wróbel: Takeda: Honoraria, Speakers Bureau; BMS: Honoraria; Novartis: Honoraria, Speakers Bureau; BeiGene: Honoraria; Janssen: Honoraria, Speakers Bureau; Roche: Honoraria, Research Funding, Speakers Bureau. Patkowska: Bristol-Myers Squibb: Other: Travel fees; Angelini Pharma: Honoraria, Other: Travel fees; Jazz Pharmaceuticals: Other: Travel fees; Pfizer: Other: Travel fees; Astellas Pharma, Inc.: Consultancy, Other: Travel fees; Servier: Honoraria, Other: Travel fees; KCR US, Inc.: Consultancy; Novartis: Honoraria, Other: Travel fees; AMGEN: Honoraria. Desai: Kura Oncology: Consultancy; Astex: Research Funding; Agios: Consultancy; Takeda: Consultancy; Bristol Myers Squibb: Consultancy; Janssen R&D: Research Funding. Lee: Innate: Consultancy, Membership on an entity's Board of Directors or advisory committees; Pin Therapeutics: Consultancy, Membership on an entity's Board of Directors or advisory committees; BMS: Consultancy, Membership on an entity's Board of Directors or advisory committees; AstraZeneca: Consultancy, Membership on an entity's Board of Directors or advisory committees. Ritchie: Astellas: Consultancy, Research Funding; Novartis: Consultancy, Honoraria, Other: travel support, Research Funding, Speakers Bureau; Incyte: Consultancy, Honoraria, Speakers Bureau; ARIAD Pharmaceuticals: Ended employment in the past 24 months, Speakers Bureau; Jazz: Consultancy, Research Funding; Takeda: Consultancy, Honoraria; Celgene/BMS: Consultancy, Other: travel support, Speakers Bureau; NS Pharma: Research Funding; Abbvie: Consultancy, Honoraria; Protaganist: Consultancy, Honoraria; Bristol Myers Squibb: Consultancy, Research Funding; Pfizer: Consultancy, Research Funding. Guzman: SeqRx: Consultancy; BridgeMedicines: Consultancy; Cellectis: Membership on an entity's Board of Directors or advisory committees; Daiichi Sankyo: Membership on an entity's Board of Directors or advisory committees. Roboz: Actinium: Consultancy; Novartis: Consultancy; Astellas: Consultancy; Amgen: Consultancy; Otsuka: Consultancy; Jazz: Consultancy; Agios: Consultancy; Jasper Therapeutics: Consultancy; AbbVie: Consultancy; Astex: Consultancy; Helsinn: Consultancy; Glaxo SmithKline: Consultancy; Daiichi Sankyo: Consultancy; Celgene: Consultancy; Blueprint Medicines: Consultancy; Bayer: Consultancy; MEI Pharma - IDMC Chair: Consultancy; Mesoblast: Consultancy; AstraZeneca: Consultancy; Bristol Myers Squibb: Consultancy; Janssen: Consultancy; Janssen: Research Funding; Pfizer: Consultancy; Roche/Genentech: Consultancy. OffLabel Disclosure: cladribine in the induction chemotherapy
- Published
- 2021
- Full Text
- View/download PDF
226. Comparison of three diagrammatic keys for the quantification of late blight in tomato leaves.
- Author
-
Corrêa, F. M., Bueno Filho, J. S. S., and Carmo, M. G. F.
- Subjects
- *
LEAF diseases & pests , *PHYTOPHTHORA infestans , *TOMATO diseases & pests , *FUNGAL diseases of plants , *PLANT disease research - Abstract
Three diagrammatic grading keys were designed for the assessment of the severity of late blight (caused by Phytophthora infestans) in tomato leaves. Simplified and broad keys considered, respectively, six (3, 12, 22, 40, 60 and 77%) and eight (3, 6, 12, 22, 40, 60, 77 and 90%) levels of disease severity, whilst a modified key based on a previous proposal for potato late blight considered six levels (1, 5, 10, 16, 32 and 50%). The keys were validated by 24 evaluators who assessed digital images of tomato leaves exhibiting different areas with lesions. Evaluator errors were compared using a mixed model in which evaluators were considered as random effects and the keys and evaluations as fixed effects. The accuracy and precision of the evaluators were compared by simple linear regression between the estimated and actual values of disease severity. The repeatability of evaluators was assessed using Pearson’s correlation coefficient. There was significant ( P ≤ 0·001) variability amongst the errors made by evaluators, although the precision of each of the three keys was high with a coefficient of determination (R2) of 0·96, 0·93 and 0·83 for the simplified, broad and modified key, respectively. Repeatability of estimations amongst the evaluators was adequate (correlation coefficients of 0·91, 0·91 and 0·90 for the three keys, respectively). The simplified and broad keys resulted in higher precision and accuracy for the estimation of severity than did the modified key. Since the simplified key considers a smaller number of disease severity levels, its use is recommended in the assessment of late blight in tomato leaves. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
227. Artificial inoculation of banana tissue culture plantlets with indigenous endophytes originally derived from native banana plants
- Author
-
Jie, Lian, Zifeng, Wang, Lixiang, Cao, Hongming, Tan, Patrik, Inderbitzin, Zide, Jiang, and Shining, Zhou
- Subjects
- *
VACCINATION , *TISSUE culture , *ENDOPHYTES , *BANANA diseases & pests , *PLANT diseases , *PLANTATIONS , *FUSARIUM oxysporum , *WILT diseases - Abstract
Abstract: Fusarium wilt disease of banana is one of the most harmful fungal diseases affecting banana production worldwide. We hypothetically proposed that the loss of indigenous endophytes in tissue culture propagation of banana might be related to increased disease severity on banana plants. In the present study, a mixture of uncultivated endophytes, which was originally derived from native healthy banana plant in plantation, was used to artificially inoculate banana tissue culture plantlets. A broad spectrum of bacterial communities was detected in the roots of artificially inoculated plantlets by 16S ribosomal RNA gene analysis, and γ-Proteobacteria was identified as the dominant group. Banana wilt pathogen Fusarium oxysporum f. sp. cubense race 4 was inoculated to the plantlets after potting to investigate disease progress. With early diagnosis of fungal pathogen infection, 54% reduction was detected in artificially inoculated plantlets compared to endophyte-free control plantlets. The re-introduction of naturally-occurring endophytes into tissue culture banana plantlets led to a 67% suppression rate of wilt disease at the fifth month after pathogen infection on plantlets in the greenhouse. In addition to disease suppression, growth of host plantlets was also promoted with the inoculation of endophytes. The artificial inoculation method provided a foundational understanding of ecological enrichment to control banana wilt disease in future. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
228. Rust resistance of some varieties and recently bred genotypes of biomass willows
- Author
-
Pei, Ming H., Lindegaard, Kevin, Ruiz, Carmen, and Bayon, Carlos
- Subjects
- *
PLANT diseases , *AGRICULTURAL pests , *PLANT quarantine , *GARDEN pests - Abstract
Abstract: Rust resistance of 23 commonly grown biomass willow varieties and 71 genotypes produced from a UK-based willow-breeding programme was tested in laboratory inoculation experiments. Leaf discs were inoculated with six pathotypes of Melampsora larici-epitea and disease was scored based on uredinial pustule area and inoculum density. In the field, rust severity of the same varieties and genotypes was scored using an assessment key. Of the varieties and commonly grown willows tested, several North American willows and Salix schwerinii×Salix viminalis ‘Bjorn’ and ‘Tora’ were highly resistant. Overall, the great majority of the willows produced through breeding showed high levels of resistance to rust. There was a significant correlation between infection-type scores obtained from the laboratory testing and field rust severity (Spearman''s rank correlation coefficient=0.624, P<1×10−6). There was also a good agreement in field disease severity scores between the years (Kendall''s coefficient of concordance=0.669, P<0.001). [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
229. CURRENT PRACTICE IN MANAGEMENT OF CROHN'S DISEASE IN WALES.
- Author
-
Dhruva, P. K. Rao, Price, P. E., and Torkington, J.
- Subjects
- *
CROHN'S disease , *DISEASE management , *WELL-being , *IMMUNOLOGICAL adjuvants , *STEROIDS , *GASTROENTEROLOGISTS - Abstract
Crohn's disease (CD) demonstrates great heterogeneity in its presentation and severity. Management of CD is similarly diverse but the aim remains the same - remission of disease activity and improvement of health related quality of life (HR-QoL). Treatment options include steroids, 5-ASA derivatives, immunomodulators and surgery. The aim of this study was to define the variation in practice of consultant gastroenterologists and colorectal surgeons treating CD in Wales. Methods: Consultant gastroenterologists and colorectal surgeons treating CD in Wales were sent a questionnaire aimed at determining their current practice and their responses were analysed. Results: Eighty-eight consultants - 46 (52%) gastroenterologists and 42 (48%) surgeons - were invited to participate in the survey. Sixty-one (69%) of them responded. Coherent practice was seen across Wales, especially with respect to diagnosis of CD in line with British Society of Castroenterology guidelines. Variation was detected in disease severity assessment and some aspects of management. Conclusion: Practice in Wales is in line with the guidelines for managing CD. While the diagnostic process follows a standard approach, variations exist in treatment and monitoring of disease. Validated disease measurement instruments are seldom used in routine practice. Disease assessment tools need to be simpler to use if they are to help objective measurement of disease activity and treatment decisions. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
230. Alzheimer’s Disease Assessment: A Review and Illustrations Focusing on Item Response Theory Techniques
- Author
-
Lisa Geraci, Steve Balsis, Jared F. Benge, Christopher J. Patrick, and Tabina K. Choudhury
- Subjects
050103 clinical psychology ,Psychometrics ,Disease ,Neuropsychological Tests ,behavioral disciplines and activities ,03 medical and health sciences ,0302 clinical medicine ,Alzheimer Disease ,Item response theory ,Humans ,Cognitive Dysfunction ,0501 psychology and cognitive sciences ,Adaptation (computer science) ,Applied Psychology ,05 social sciences ,Neuropsychology ,Reproducibility of Results ,Cognition ,Magnetic Resonance Imaging ,Test (assessment) ,Clinical Psychology ,Disease assessment ,Psychological Theory ,Psychology ,Biomarkers ,030217 neurology & neurosurgery ,Cognitive psychology - Abstract
Alzheimer’s disease (AD) affects neurological, cognitive, and behavioral processes. Thus, to accurately assess this disease, researchers and clinicians need to combine and incorporate data across these domains. This presents not only distinct methodological and statistical challenges but also unique opportunities for the development and advancement of psychometric techniques. In this article, we describe relatively recent research using item response theory (IRT) that has been used to make progress in assessing the disease across its various symptomatic and pathological manifestations. We focus on applications of IRT to improve scoring, test development (including cross-validation and adaptation), and linking and calibration. We conclude by describing potential future multidimensional applications of IRT techniques that may improve the precision with which AD is measured.
- Published
- 2017
- Full Text
- View/download PDF
231. Comparison of psoriasis and atopic dermatitis guidelines-an argument for aggressive atopic dermatitis management
- Author
-
Peter A. Lio and Mary E. Lohman
- Subjects
Systemic disease ,medicine.medical_specialty ,Dermatology ,Dermatitis, Atopic ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Quality of life (healthcare) ,Disease severity ,Psoriasis ,Humans ,Medicine ,030212 general & internal medicine ,Disease management (health) ,business.industry ,Atopic dermatitis ,medicine.disease ,Rash ,Practice Guidelines as Topic ,Pediatrics, Perinatology and Child Health ,Quality of Life ,Disease assessment ,medicine.symptom ,business - Abstract
The development of effective systemic treatments has revolutionized the treatment of inflammatory skin diseases. The availability of safe new treatments and the understanding of psoriasis as a systemic disease with comorbidities and effects on quality of life have driven the current aggressive treatment paradigm of psoriasis. Historically the morbidity of atopic dermatitis (AD) has been dismissed, given the perception of AD as "just" a rash. Differences in the guidelines for psoriasis and AD management may suggest variations in the current conceptualization of disease severity and effects on quality of life. Published guidelines from the American Academy of Dermatology for the management of psoriasis and AD were reviewed. We recorded the similarities and differences in disease assessment and therapy. The threshold to use biologic agents for moderate to severe psoriasis highlights the aggressive nature of modern psoriasis treatment. AD guidelines include an assessment of quality of life but do not designate a disease severity threshold for systemic treatment. AD and psoriasis have a tremendous effect on quality of life. The AD guidelines have a less aggressive approach to disease management than the psoriasis guidelines. We should think critically about rapid advancement to systemic agents in AD management, especially now that more and better agents are being developed.
- Published
- 2017
- Full Text
- View/download PDF
232. Abundance of willow rust (Melampsora sp.) on different willow clones in Estonian energy forest plantations.
- Author
-
Toome, Merje, Heinsoo, Katrin, and Luik, Anne
- Subjects
- *
MELAMPSORA , *MELAMPSORACEAE , *TREE farms , *SEWAGE purification , *PLANTATIONS , *FOREST management - Abstract
The abundance of leaf rust (Melampsora sp.) was assessed on four willow clones in four experimental Estonian willow short-rotation forest plantations. Three plantations were established on poor mineral soil and one was constructed for wastewater purification. Clones 78183 and 81090 were most severely damaged in all four plantations, whereas clones 78021 and 78195 were fairly resistant to rust. In addition to clone type, the number of uredinia on leaves depended on plantation, sampling date, and fertilization. Infection increased significantly during the growing season, and the leaves collected from fertilized plants had more and larger rust pustules than those from unfertilized plants. Uredinia were smaller on older shoots and larger on younger shoots. [ABSTRACT FROM AUTHOR]
- Published
- 2006
233. Alzheimer-Demenz: Verlauf und Belastung der Pflegepersonen
- Author
-
E. Schneider, M. Lieb, K. Hager, C. Henneges, and S. Kraemer
- Subjects
medicine.medical_specialty ,Activities of daily living ,business.industry ,Disease progression ,General Medicine ,Caregiver burden ,medicine.disease ,Alzheimer dementia ,03 medical and health sciences ,Psychiatry and Mental health ,0302 clinical medicine ,Neurology ,Internal medicine ,medicine ,Dementia ,030212 general & internal medicine ,Neurology (clinical) ,Disease assessment ,Alzheimer's disease ,business ,Psychosocial ,030217 neurology & neurosurgery - Abstract
The GERAS study is an international observational study with dementia patients of the Alzheimer type (AD) and their caregivers in everyday care. The 18-month data recorded in Germany are presented. Disease progression, medical and psychosocial consequences for both patients and caregivers were recorded using commonly used tests in clinical care: the mini mental status examination (MMSE), Alzheimer's disease assessment scale (ADAS-Cog14), Alzheimer's disease cooperative study activities of daily living inventory (ADCS-ADL), neuropsychiatric inventory (NPI-12), resource utilization in dementia (RUD) and the Zarit burden interview (ZBI). Definition of AD severity level (MMSE): 21-26 mild (miAD), 15-20 moderate (moAD)
- Published
- 2017
- Full Text
- View/download PDF
234. Visual and PCR assessment of light leaf spot ( Pyrenopeziza brassicae) on winter oilseed rape ( Brassica napus) cultivars.
- Author
-
Karolewski, Z., Fitt, B. D. L., Latunde-Dada, A. O., Foster, S. J., Todd, A. D., Downes, K., and Evans, N.
- Subjects
- *
LEAF spots , *LEAF diseases & pests , *BARLEY net-spot blotch disease , *EXPERIMENTAL agriculture , *BRASSICA , *OILSEED plants , *HYDROCARBON-producing plants (Organisms) , *ENERGY crops , *AGRICULTURAL experimentation - Abstract
Methods to assess light leaf spot ( Pyrenopeziza brassicae) on winter oilseed rape cultivars were compared in laboratory, controlled-environment and field experiments. In controlled-environment experiments with seedling leaves inoculated at GS 1,4, the greatest differences in percentage area affected by P. brassicae sporulation were observed with inoculum concentrations of 4 × 103 or 4 × 104 spores mL−1, rather than 4 × 102 or 4 × 105 spores mL−1, but older leaves had begun to senesce before assessment, particularly where they were severely affected by P. brassicae. In winter oilseed rape field experiments, a severe light leaf spot epidemic developed in 2002/03 (inoculated, September/October rainfall 127·2 mm) but not in 2003/04 (uninoculated, September/October rainfall 40·7 mm). In-plot assessments discriminated between cultivars best in February/March in 2003 and June in 2004, but sometimes failed to detect plots with many infected plants (e.g. March/April 2004). Ranking of cultivar resistance differed between seedling experiments done under controlled-environment conditions and field experiments. The sensitivity of detection of P. brassicae DNA extracted from culture was greater using the PCR primer pair PbITSF/PbITSR than using primers Pb1/Pb2. P. brassicae was detected by PCR (PbITS primers) in leaves from controlled-environment experiments immediately and up to 14 days after inoculation, and in leaves sampled from field experiments 2 months before detection by visual assessment. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
235. Comparison of Severity Assessment Methods for Predicting Yield Loss to Rhizoctonia Foliar Blight in Soybean.
- Author
-
Stetina, K. C., Stetina, S. R., and Russin, J. S.
- Subjects
- *
RHIZOCTONIA , *SOYBEAN diseases & pests , *PLANT diseases , *AGRICULTURAL pests , *AGONOMYCETACEAE - Abstract
Rhizoctonia foliar blight, caused by Rhizoctonia solani Kuhn anastomosis group 1, causes rapid and severe destruction of soybean foliage and pods during hot, wet weather. The objectives of this study were to determine the yield components affected by this disease and whether rating pod damage or foliar damage provides a more reliable method of assessing disease severity relative to impact on yield. Disease severity in the moderately resistant cv. NK S57-11 and the susceptible cv. Buckshot 723 was assessed in field plots in 1996 and 1997 using foliar and pod ratings (0-to-10 scale corresponding to 0 to 100% of tissue affected). Based on results from regression analysis, pod number, seed number, and seed weight per plot decreased as disease severity increased, whereas the proportion of partially filled pods and the weight of 100 seed were not affected. Yield loss appeared to be due primarily to loss of entire pods. Foliar and pod assessments of disease severity correlated positively in 1996 (r = 0.8343) and 1997 (r = 0.5958) for both cultivars, which suggests that either method can be used to identify relative differences among cultivars. However, pod assessments accounted for more variability than foliar assessments under low-disease conditions. Plants exhibiting moderate to severe symptoms of Rhizoctonia foliar blight also retained green stems and pods at harvest, which was evidence of delayed maturity. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
236. Quantification of the effects of Septoria tritici blotch on wheat leaf gas exchange with respect to lesion age, leaf number, and leaf nitrogen status.
- Author
-
Robert, Corinne, Bancal, Marie-Odile, Lannou, Christian, and Ney, Bertrand
- Subjects
- *
WHEAT speckled leaf blotch , *SIMULATION methods & models , *PATHOGENIC microorganisms , *AGRICULTURAL pests , *PHOTOSYNTHESIS - Abstract
Quantification of the damaging effects of pathogens on diseased plants and inclusion of these damaging functions in crop simulation models is of great importance for a more complete understanding of yield response to diseases. In this study, the effect of Septoria tritici blotch (STB) on net photosynthetic and dark respiration rates of wheat flag leaves was quantified. Bastiaans' model: Y=(1–x)β was used to characterize the relationship between relative leaf photosynthesis (Y, considering Ynet and Ygross) and STB severity (with x the proportion of the diseased area). The value of β indicates whether the effect of disease on photosynthesis is larger (β >1), lower (β <1), or equal (β =1) to the proportion of visible diseased area. In the experimental conditions used here, leaf nitrogen content (in a range from 0.18 to 0.24 mg cm−2), and leaf number (flag and second leaves) did not significantly influence the effect of STB on leaf gas exchange. By contrast, damage depended strongly on the developmental stages of the STB lesions. STB lesions had no effect on inoculated leaves before visible symptoms appeared. Chlorotic symptoms had less effect on leaf net photosynthetic rate than could be accounted for by the visible diseased area (βnet=0.81). The effect of necrotic lesions on the leaf net photosynthetic capacity was slightly greater than that accounted for by visible symptoms (βnet=1.35). Our results suggest that the effect of the necrotic symptoms on the net photosynthesis expressed by βnet >1 is due to a combination of a decrease in the gross photosynthesis (βgross still >1) and to an increase in the dark respiration rate (βgross<βnet). Finally, it is discussed how the results could improve the prediction of crop loss caused by an STB epidemic in wheat fields. [ABSTRACT FROM PUBLISHER]
- Published
- 2006
- Full Text
- View/download PDF
237. Disease assessment methods and their use in simulating growth and yield of peanut crops affected by leafspot disease.
- Author
-
Adomou, M., Prasad, P. V. V., Boote, K. J., and Detongnon, J.
- Subjects
- *
PEANUTS , *NECROSIS , *CULTIVARS , *PLANT diseases - Abstract
Peanut ( Arachis hypogaea) crops in Benin often experience late leafspot ( Cercosporidium personatum), which causes severe yield losses associated with leaf defoliation and necrosis. The objective of this research was to determine the best method of disease assessment and to test its utility in the CROPGRO-peanut model to simulate growth and yield as affected by late leafspot in early and late maturing peanut cultivars grown at different sowing dates under rain-fed conditions (without irrigation) in northern Benin. Two peanut cultivars TS 32-1 and 69–101 were sown on three dates between May and August during 1998 and 1999. In both years there was severe occurrence of late leafspot and the progression of disease was earlier and faster with later sowing dates. Overall, the long duration cultivar 69–101 produced greater yield than the short duration cultivar TS 32-1. The CROPGRO-peanut model was able to predict and simulate the observed crop and pod dry matter over time when input on percent diseased leaf area and percent defoliation were provided. Of several disease assessments, the best approach was to input measured percent main-stem defoliation above the fourth node and percent diseased leaf area estimated from visual leafspot score. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
238. Evaluation of foliar resistance in potato toPhytophthora infestansbased on an international field trial network.
- Author
-
Hansen, J. G., Koppel, M., Valskyte, A., Turka, I., and Kapsa, J.
- Subjects
- *
POTATOES , *PHYTOPHTHORA , *CULTIVARS , *FOLIAR application of agricultural chemicals , *REGRESSION analysis , *INTERNET - Abstract
During the period 2000–03, local potato cultivars in Estonia, Latvia, Lithuania, Poland and Denmark were tested for foliar resistance toPhytophthora infestans(late blight) in an international field trial network. Four standard cultivars were included in the trials: Sava, Oleva, Danva and Kuras. Primary disease-assessment data were entered into a common database, and parameters from the disease progress curves were calculated and made available on interactive web pages. A regression model, using relative area under disease progress curve (RAUDPC) values for cv. Oleva as a reference, was developed for the estimation of 1–9 scale values, where 1 = most susceptible. Standard deviations for the estimated 1–9 scale values and a nonparametric rank stability analysis of RAUDPC were used to evaluate the stability of resistance of the cultivars. Overall, the results showed stability of resistance for cvs Sava, Oleva and Danva, but not for Kuras. Use of the Internet-based Web-Blight service in this study facilitated comparison of results among countries for the level and stability of resistance. The estimated 1–9 scale values were similar to, or slightly lower than, those from official cultivar lists or from the European Cultivated Potato Database, especially for the more resistant cultivars. Possible reasons for discrepancies from different sources and locations are discussed. It is concluded that RAUPDC and the derived 1–9 scale values are useful for ranking cultivars for resistance toP. infestans, but this information is not detailed enough for use in a decision support system for late blight control. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
239. Development of a disease severity rating scale for plane tree anthracnose.
- Author
-
Tello, María-Luisa, Redondo, Cristina, Gaforio, Laura, Pastor, Silvina, and Mateo-Sagasta, Eloy
- Subjects
ANTHRACNOSE ,GNOMONIACEAE ,ORNAMENTAL plants ,DEFOLIATION ,PLANT shoots - Abstract
Anthracnose caused by the fungus Apiognomonia veneta (Sacc. et Speg.) Höhnel., is the most important and frequent disease affecting mature ornamental plane trees ( Platanus × hybrida Brot.= P. × acerifolia (Ait.)Willd.) of central Spain. Symptoms of the disease are: leaf vein and petiole necrosis, bud death, defoliation, proliferation of shoots growing in whorls, short internodes, cankers, necrotic lesions and twigs and branches growing in angles. Based on our previous experience, a disease severity rating scale (DSRS) has been established, consisting of six levels: 0=healthy, 1=initial, 2=low, 3=medium, 4=high and 5=dead. In order to achieve a better and more efficient measure of disease intensity we tried to quantify this visual scale using mathematical criteria. In 2000, 610 mature trees up to 200 years old, divided into 4 age classes, were selected and systematically evaluated using a visual estimation based method. The trees were located in central Spain, mainly in two periurban areas of the town of Aranjuez (south of Madrid) and in three urban areas of Madrid city. Trees were observed in late spring, summer and winter. We recorded visual estimation of disease severity, foliage cover, healthy new shoots, dead branches, shoot growth in whorls and branch growth in angles. The statistical relationship between the parameters, disease severity and all the variables recorded (defoliation, healthy new shoots, etc.) has been evaluated. “Leaf density”, “dead branches” and “healthy shoots” were the variables that help to discriminate better between the different levels of the DSRS. A clearer definition of the different phases of disease severity will facilitate the application of possible control methods and the prediction of the behaviour of other Platanus spp. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
240. Does Size Really Matter?
- Author
-
Nayantara Coelho-Prabhu and Sunanda V. Kane
- Subjects
medicine.medical_specialty ,Hepatology ,business.industry ,Gastroenterology ,Rectum ,Disease ,Time optimal ,digestive system diseases ,Odds ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Lead time bias ,030220 oncology & carcinogenesis ,Internal medicine ,Post-hoc analysis ,Medicine ,030211 gastroenterology & hepatology ,Disease assessment ,business ,Mass screening - Abstract
Ileocolonoscopy remains the mainstay of objective disease assessment in Crohn's Disease, and various validated indices are used to grade severity of the disease. The most commonly used indices are the Simple Endoscopic Score for Crohn's Disease (including the size of ulcers) and the Crohn's Disease Endoscopic Index of Severity (including the depth of ulcers). These measurements are highly subjective, especially the depth of an ulcer, and are based solely on the discretion of the endoscopist coupled with the imaging capabilities of the colonoscope and adequacy of the bowel prep. Narula et al. undertook a post hoc analysis of baseline predictors of endoscopic remission (ER) at week 26 in a subset (172 of 508) of moderate-severe Crohn's disease patients participating in the SONIC trial. The authors found no significant differences in the odds of achieving ER when comparing overall or segmental severe inflammation (high Simple Endoscopic Score for Crohn's Disease [>16 overall or >3 per segment] or Crohn's Disease Endoscopic Index of Severity [>12 overall or >3 per segment] scores) with moderate inflammation. The number of affected segments involved also did not impact the likelihood of achieving week 26 ER. The authors then found a potentially synergistic effect with large and deep ulcers in the ileum and rectum. The optimal time to assess whether ulcers ultimately heal or not is unknown, but waiting longer than 26 weeks may negate any lead time bias regarding ulcer size. Therefore, similar to many areas of life, it is likely that size ultimately does not matter, but instead location, location, and location.
- Published
- 2020
- Full Text
- View/download PDF
241. OP0218 CENTRAL NERVOUS SYSTEM PAIN RESPONSE AND COMPONENTS OF DISEASE ACTIVITY IN RA PATIENTS AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO: A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL
- Author
-
M. Sergeeva, J. A. P. Da Silva, Melanie Hagen, Stephanie Finzel, S. Strobelt, Georg Schett, J. Prade, Axel J. Hueber, Reinhard E. Voll, A. Doerfler, Jürgen Rech, Hannah Schenker, Frank Behrens, Christoph Baerwald, Eugen Feist, A. Kleyer, L. Valor, M. Selvakumar, David Simon, Koray Tascilar, Nemanja Damjanov, L. Konerth, Andreas Hess, and Verena Schönau
- Subjects
medicine.medical_specialty ,business.industry ,Immunology ,Placebo ,General Biochemistry, Genetics and Molecular Biology ,Disease activity ,Rheumatology ,Internal medicine ,Post-hoc analysis ,Immunology and Allergy ,Medicine ,In patient ,Disease assessment ,Post treatment ,business ,After treatment ,Linear trend - Abstract
Background:We have previously observed in RA patients that central nervous system (CNS) response to compression of a painful joint, measured using functional MRI (fMRI) of the brain as the number of blood oxygen level dependent (BOLD) signal positive voxels, is rapidly ameliorated, much earlier than any clinical response with anti-TNF treatment and a high baseline CNS pain response could predict better response to certolizumab pegol (CZP) treatment. Pre-CePRA was designed and conducted to test this effect in a randomized, placebo controlled trial of CZP and showed an incremental linear trend of DAS28 low disease activity (LDA) across study groups treated with placebo, and two CZP arms stratified as low or high pre-treatment CNS pain response.Objectives:To explore and describe pre-treatment CNS pain response associations with post treatment course of RA disease activity components and patient-physician discrepancy in global disease assessment.Methods:Patients fulfilling the 2010 ACR/EULAR classification criteria with moderate-severe disease activity (DAS-28>3.2) under stable DMARD treatment were recruited. Patients underwent an fMRI scan, stratified by a whole-brain BOLD positive voxel count threshold of 700 units and randomized to treatment with CZP or placebo in a 2:1 ratio. We descriptively assessed components of RA disease activity (Table 1 + 2). We summarized the mean results and 95% confidence intervals of these measurements at study timepoints and compared the 3 study groups at week 12 using one-way ANOVA and post-hoc Tukey tests.Results:156 eligible patients were screened and 139 (99 females, 71%) patients with moderate-high disease activity were randomized. ANOVA and pairwise comparisons showed that PGA-VAS improvement was larger in the CZP-H group whereas more similar to that in placebo in the CZP-L group. PhysGA-VAS however was similarly reduced in both CZP groups. Patients in the CZP-L group constantly rated their pain numerically higher than physicians whereas in the CZP-H group an initially higher discrepancy numerically reduced over time.Conclusion:These results suggest that improved patient global disease activity assessment could be the main driver of improved DAS-28 LDA rates with CZP treatment in patients with a high CNS pain response. Our findings indicate a potential role of fMRI imaging of the brain to further understand disease activity perception in RA patients.Figure 1.Course of disease activity components through trial timepoints. *indicates log-transformed y axis. *#x002A; Discrepancy equals Patient global minus physician global assessment.Disclosure of Interests:Hannah Schenker: None declared, Jürgen Rech Consultant of: BMS, Celgene, Novartis, Roche, Chugai, Speakers bureau: AbbVie, Biogen, BMS, Celgene, MSD, Novartis, Roche, Chugai, Pfizer, Lilly, Koray Tascilar: None declared, Melanie Hagen: None declared, Verena Schönau: None declared, Marina Sergeeva: None declared, Mageshwar Selvakumar: None declared, Laura Konerth: None declared, Jutta Prade: None declared, Sandra Strobelt: None declared, Larissa Valor: None declared, Axel Hueber Grant/research support from: Novartis, Lilly, Pfizer, EIT Health, EU-IMI, DFG, Universität Erlangen (EFI), Consultant of: Abbvie, BMS, Celgene, Gilead, GSK, Lilly, Novartis, Speakers bureau: GSK, Lilly, Novartis, David Simon Grant/research support from: Else Kröner-Memorial Scholarship, Novartis, Consultant of: Novartis, Lilly, Arnd Kleyer Consultant of: Lilly, Gilead, Novartis,Abbvie, Speakers bureau: Novartis, Lilly, Frank Behrens Grant/research support from: Abbvie, Pfizer, Roche, Chugai, Janssen, Consultant of: Abbvie, Pfizer, Roche, Chugai, UCB, BMS, Celgene, MSD, Novartis, Biotest, Janssen, Genzyme, Lilly; Boehringer; Sandoz, Speakers bureau: Abbvie, Pfizer, Roche, Chugai, UCB, BMS, Celgene, MSD, Novartis, Biotest, Janssen, Genzyme, Lilly; Boehringer; Sandoz, José Antonio P. da Silva Grant/research support from: Pfizer, Abbvie, Consultant of: Pfizer, AbbVie, Roche, Lilly, Novartis, Christoph Baerwald Consultant of: CGB received speaker or consulting fees from AbbVie, Paid instructor for: CGB received speaker or consulting fees from AbbVie, Speakers bureau: CGB received speaker or consulting fees from AbbVie, Stephanie Finzel: None declared, Reinhard Voll: None declared, Eugen Feist Consultant of: Novartis, Roche, Sobi, Lilly, Pfizer, Abbvie, BMS, MSD, Sanofi, Speakers bureau: Novartis, Roche, Sobi, Lilly, Pfizer, Abbvie, BMS, MSD, Sanofi, Arnd Doerfler: None declared, Nemanja Damjanov Grant/research support from: from AbbVie, Pfizer, and Roche, Consultant of: AbbVie, Gedeon Richter, Merck, Novartis, Pfizer, and Roche, Speakers bureau: AbbVie, Gedeon Richter, Merck, Novartis, Pfizer, and Roche, Andreas Hess: None declared, Georg Schett Speakers bureau: AbbVie, BMS, Celgene, Janssen, Eli Lilly, Novartis, Roche and UCB
- Published
- 2020
- Full Text
- View/download PDF
242. Relationship between canopy reflectance and yield loss due to disease in barley.
- Author
-
Newton, A. C., Hackett, C. A., Lowe, R., and Wale, S. J.
- Subjects
- *
BARLEY diseases & pests , *PLANT diseases , *FUNGICIDES , *CULTIVARS , *FERTILIZERS , *LEAVES - Abstract
Reflectance from barley field trial plots was measured to determine whether it could be used as an accurate estimate of disease and yield response to fungicide, and whether this was consistent over a range of agronomic factors. Three trials were used to test the effects of cultivar, assessment date, fungicide and dose, different disease and fertiliser. Correlations with predominant disease and resulting yield loss were high, often better than visual disease or green leaf area measurements alone. Certain ratios of two reflectance wavelength measurements were more robust predictors than single wavelengths. Cultivar and development stage had a large influence on measurements and calibration for such morphology-based characters would be essential for practical deployment. Whilst weather conditions and solar angle restrict opportunities for usage of reflectance tools such as the 'Cropscan Radiometer', it may prove useful in crop loss assessments as an additional objective tool. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
243. Comparison of single-point alfalfa yield models based on visual disease intensity and remote sensing assessments.
- Author
-
Guan, Jie and Nutter, Jr., Forrest W.
- Subjects
- *
ALFALFA , *PLANT diseases , *REMOTE sensing , *CROP yields , *FOLIAR diagnosis - Abstract
Compares alfalfa yield models based on visual disease intensity and remote sensing assessments. Foliar disease levels in alfalfa; Relationship between alfalfa attainable yield potential and damage coefficients.
- Published
- 2004
- Full Text
- View/download PDF
244. Evaluation of disease assessment methods in quinoa for their ability to predict yield loss caused by downy mildew.
- Author
-
Danielsen, S. and Munk, L.
- Subjects
MILDEW ,PERONOSPORA ,GOOSEFOOTS - Abstract
Seven disease assessment methods to measure severity of downy mildew (Peronospora farinosa f.sp. chenopodii) were tested in eight cultivars of quinoa (Chenopodium quinoa) in two field experiments in Peru, one at low (Lima) and one at high (Huancayo) disease pressure. Two levels of downy mildew were established by means of fungicide treatments. Area under disease progress curve (AUDPC) values were calculated for each method and correlated to the grain yield. In addition to the severity measurements, spectral reflectance was measured throughout the growth season in Huancayo and area under reflectance curve (AURC) values calculated and correlated to yield. The disease level was ten-fold higher in Huancayo compared to Lima. AUDPC based on the Three-leaf method (mean disease severity of three leaves per plant selected randomly from the lower, middle and upper part of the plant), showed the highest negative correlation to yield (
r=−0.736 ) and is regarded as the best method to predict yield loss caused by downy mildew. In addition, this method proved to be the quickest and easiest compared to the other six methods included in the study, which were based on assessments of disease severity of the entire plant or parts of the plant. Yield losses recorded in the tested cultivars ranged from 33% to 99% under the high-disease conditions. The reflectance method was superior to all other methods by showing a higher correlation between AURC and yield (r=0.853 ), which is explained by its ability to measure pathogen-induced defoliation. Remote sensing is an excellent tool to compare the effect of treatments on disease severity within a cultivar. However, the method does not allow for comparison of disease severity among cultivars as the spectral reflectance is determined by size, shape and colour of the plant.The Three-leaf method provides an easy, cheap and readily applicable tool for researchers and plant breeders to study downy mildew of quinoa, characterise germplasm for resistance and compare results across regions and years. [Copyright &y& Elsevier]- Published
- 2004
- Full Text
- View/download PDF
245. Photosynthetic consequences of Marssonina leaf spot differ between two poplar hybrids.
- Author
-
Erickson, J. E., Stanosz, G. R., and Kruger, E. L.
- Subjects
- *
POPLARS , *LEAVES , *PHOTOSYNTHESIS , *MARSSONINA brunnea , *GAS exchange in plants , *LEAF spots , *PHYTOPATHOGENIC microorganisms - Abstract
In foliage of two hybrid poplars, clone DN-34 (Populus deltoides ′ P. nigra) and clone NM-6 (P. nigra × P maximowiczii), we examined relationships between photosynthesis and severity of leaf spot induced by Marssonina brunnea f. sp. brunnea, a common disease of many tree species in the Populus genus with the potential to affect growth. Gas exchange was measured on asymptomatic and diseased foliage in monoculture stands of each clone. The equation Y = (1 - x)β was used to characterize the relationship between relative photosynthesis (Y) and percent leaf spot (x), where β represents the ratio between functional impairment and measured lesion area. Leaf photosynthesis was strongly and negatively correlated with leaf spot severity in both hybrids, and β-values indicated that photosynthetic impairment extended beyond visibly damaged leaf tissue. However, large differences in β between hybrids indicated differential photosynthetic consequences for a given leaf spot severity. For each hybrid, values of β were positively related to photosynthetic photon flux density incident upon the leaf during gas exchange measurement. Declines in leaf photosynthesis appeared to result from a disruption of the photosynthetic apparatus by the invading pathogen. However, specific causes for the differential photosynthetic responses of the two hybrids to disease remained elusive. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
246. Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer's disease
- Author
-
Montse Pujol, Mireia Dalmases, Anna Michela Gaeta, Adriano D.S. Targa, Gerard Piñol-Ripoll, Anna Carnes, Ramon Farré, Olga Minguez, Ferran Barbé, Iván Benítez, Aurora Gibert, Faride Dakterzada, Gerard Torres, Carmen Jorge, Manuel Sánchez-de-la-Torre, and Ricard López
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Sleep Apnea, Obstructive ,medicine.diagnostic_test ,business.industry ,Significant difference ,Cognition ,Disease ,Polysomnography ,Sleep in non-human animals ,03 medical and health sciences ,0302 clinical medicine ,030228 respiratory system ,Alzheimer Disease ,Internal medicine ,medicine ,Humans ,In patient ,Cognitive Dysfunction ,Disease assessment ,Cognitive decline ,business ,030217 neurology & neurosurgery - Abstract
We evaluated the influence of untreated obstructive sleep apnoea (OSA) on the magnitude of cognitive decline and on several cognitive subdomains in patients with mild-to-moderate Alzheimer's disease.In this single-centre study, 144 patients were recruited prospectively from a cognitive impairment unit and underwent overnight polysomnography.The mean±sd change in the Alzheimer's Disease Assessment Scale cognitive subscale (ADAS-cog) score at 12 months was 3.19±5.61 in the non-OSA group and 0.08±5.62 in the OSA group, with an intergroup difference of −3.36 (95% CI 0.19–0.16; p=0.002). We did not observe a significant difference in any cognitive subdomains at 12 months. Regarding Mini-Mental State Examination scores at 36 months, the mean change was 1.69 (95% CI −1.26–4.64; p=0.445). No significant differences were found among different OSA severity groups.We observed that ADAS-cog scores were better in the OSA group than in the non-OSA group by a statistically but not clinically significant margin. We did not find differences in the different cognitive subdomains after 1 year or in global cognition after 3 years of follow-up.
- Published
- 2020
247. How Accurately Do Patients and Their Care Partners Report Results of Amyloid-β PET Scans for Alzheimer's Disease Assessment?
- Author
-
Hailey J James, Megan Shepherd-Banigan, Emmanuelle Belanger, Brenda L. Plassman, Terrie Fox Wetle, Steven J. Lippmann, Courtney Harold Van Houtven, and James R. Burke
- Subjects
0301 basic medicine ,Male ,Pediatrics ,medicine.medical_specialty ,Amyloid β ,Concordance ,Disease ,Article ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Alzheimer Disease ,medicine ,Dementia ,Humans ,Cognitive Dysfunction ,Cognitive impairment ,Reimbursement ,Aged ,Aged, 80 and over ,Amyloid beta-Peptides ,business.industry ,General Neuroscience ,Cognition ,General Medicine ,Middle Aged ,medicine.disease ,Psychiatry and Mental health ,Clinical Psychology ,030104 developmental biology ,Caregivers ,Positron-Emission Tomography ,Female ,Disease assessment ,Geriatrics and Gerontology ,Patient Participation ,business ,030217 neurology & neurosurgery - Abstract
Background Amyloid-β PET scans will likely become an integral part of the diagnostic evaluation for Alzheimer's disease if Medicare approves reimbursement for the scans. However, little is known about patients' and their care partners' interpretation of scan results. Objective This study seeks to understand how accurately patients with mild cognitive impairment (MCI) or dementia and their care partners report results of amyloid-β PET scans and factors related to correct reporting. Methods A mixed-methods approach was used to analyze survey data from 1,845 patient-care partner dyads and responses to open-ended questions about interpretation of scan results from a sub-sample of 200 dyads. Results Eighty-three percent of patients and 85% of care partners correctly reported amyloid-β PET scan results. Patients' higher cognitive function was associated with a small but significant decrease in the predicted probability of not only patients accurately reporting scan results (ME: -0.004, 95% CI: -0.007, -0.000), but also care partners accurately reporting scan results (ME: -0.006, 95% CI: -0.007, -0.001), as well as decreased concordance between patient and care partner reports (ME: -0.004, 95% CI: -0.007, -0.001). Content analysis of open-ended responses found that participants who reported the scan results incorrectly exhibited more confusion about diagnostic terminology than those who correctly reported the scan results. Conclusion Overall, patients with MCI or dementia showed high rates of accurate reporting of amyloid-β PET scan results. However, responses to questions about the meaning of the scan results highlight the need for improved provider communication, including providing written explanations and better prognostic information.
- Published
- 2020
248. Assessment of Acute Pulmonary Embolism by Computer-Aided Technique: A Reliability Study
- Author
-
Fen'e Hao, Zhenting Sun, Lei Zhao, Youmin Guo, and Aishi Liu
- Subjects
Male ,Medical Technology ,medicine.medical_specialty ,Intraclass correlation ,Cost-Benefit Analysis ,Embolism ,Pulmonary Artery ,030204 cardiovascular system & hematology ,Severity of Illness Index ,Time cost ,03 medical and health sciences ,0302 clinical medicine ,Reliability study ,Image Processing, Computer-Assisted ,medicine ,Humans ,Diagnosis, Computer-Assisted ,Reliability (statistics) ,business.industry ,Angiography ,Reproducibility of Results ,General Medicine ,Middle Aged ,medicine.disease ,Confidence interval ,Pulmonary embolism ,Dimensional Measurement Accuracy ,030220 oncology & carcinogenesis ,Computer-aided ,Female ,Radiology ,Disease assessment ,Pulmonary Embolism ,Tomography, X-Ray Computed ,business - Abstract
BACKGROUND Acute pulmonary embolism is one of the most common cardiovascular diseases. Computer-aided technique is widely used in chest imaging, especially for assessing pulmonary embolism. The reliability and quantitative analyses of computer-aided technique are necessary. This study aimed to evaluate the reliability of geometry-based computer-aided detection and quantification for emboli morphology and severity of acute pulmonary embolism. MATERIAL AND METHODS Thirty patients suspected of acute pulmonary embolism were analyzed by both manual and computer-aided interpretation of vascular obstruction index and computer-aided measurements of emboli quantitative parameters. The reliability of Qanadli and Mastora scores was analyzed using computer-aided and manual interpretation. RESULTS The time costs of manual and computer-aided interpretation were statistically different (374.90±150.16 versus 121.07±51.76, P
- Published
- 2020
- Full Text
- View/download PDF
249. Development and validation of a standard area diagram set to assess powdery mildew severity on watermelon leaves
- Author
-
Flávio de França Souza, Henrique Duarte, Alexandre Sandri Capucho, Francinete Alves Nascimento, Francine Hiromi Ishikawa, FRANCINETE ALVES NASCIMENTO, UNIVASF, HENRIQUE DA SILVA SILVEIRA DUARTE, UFPR, FLAVIO DE FRANCA SOUZA, CPATSA, FRANCINE HIROMI ISHIKAWA, UNIVASF, and ALEXANDRE SANDRI CAPUCHO, UNIVASF.
- Subjects
0106 biological sciences ,Coefficient of determination ,Correlation coefficient ,Agriculture (General) ,severity ,Watermelons ,01 natural sciences ,S1-972 ,Avaliação de doenças ,03 medical and health sciences ,Podosphaera xanthii ,Melancia ,Statistics ,Oídio ,Doença ,Disease severity ,030304 developmental biology ,Mathematics ,0303 health sciences ,General Veterinary ,biology ,Diagram ,Agriculture ,biology.organism_classification ,Plant disease ,disease assessment ,Concordance correlation coefficient ,Correlation analysis ,Animal Science and Zoology ,Agronomy and Crop Science ,Powdery mildew ,Citrullus lanatus ,010606 plant biology & botany - Abstract
The development and validation of a standard area diagram set (SADs) was proposed in this study to assess the severity of powdery mildew (Podosphaera xanthii) in watermelon (Citrullus lanatus) leaves. The SADs proposed has twelve levels of severity, varying from 0.07 to 100%. The SADs were validated by 16 raters who had no previous experience in evaluating plant disease severity. Initially, the estimation of severity was performed without the use of the SADs in leaves with different levels of severity. In a second moment, the same raters estimated the disease severity using the SADs proposed. By Lin?s concordance correlation analysis, there was an improvement in precision (coefficient of correlation, r = 0.878 and r = 0.959, without and with SADs, respectively) and accuracy (bias correction factor, Cb = 0.830 and 0.982, without and with SADs, respectively) using SADs when compared to the non-use of SADs. The agreement (Lin?s concordance correlation coefficient, ρc = 0.734 and 0.952 without and with SADs, espectively) also improved using SADs. Severity estimates inter-rater were more reliable when using SADs (coefficient of determination, R2 = 0.681 without and R2 = 0.864 with SADs; Intra-class correlation coefficient, ρ = 0.759 and ρ = 0.928, without and with SADs, respectively). Therefore, SADs improved precision, accuracy and reliability of powdery mildew severity on watermelon leaves. Made available in DSpace on 2022-10-11T17:08:20Z (GMT). No. of bitstreams: 1 Development-and-validation-of-a-standard-area-diagram-set-to-assess-powdery-mildew-2020.pdf: 2583945 bytes, checksum: 155f303e6ffe1d00f0091d31034fa1b4 (MD5) Previous issue date: 2020
- Published
- 2020
250. A Framework for the Discovery of Retinal Biomarkers in Optical Coherence Tomography Angiography (OCTA)
- Author
-
Dan Pugh, Rik Sarkar, Alessandro Fontanella, Tariq E. Farrah, Shareen Forbes, Laura Reid, Tom MacGillivray, Ylenia Giarratano, Baljean Dhillon, Neeraj Dhaun, Miguel O. Bernabeu, Jie Lian, Rayna Andreeva, and Alisa Pavel
- Subjects
business.industry ,Topological information ,Retinal ,Optical coherence tomography angiography ,Diabetic retinopathy ,Computational biology ,medicine.disease ,chemistry.chemical_compound ,chemistry ,Vascular network ,medicine ,Retinal imaging ,Disease assessment ,business ,Interpretability - Abstract
Recent studies have demonstrated the potential of OCTA retinal imaging for the discovery of biomarkers of vascular disease of the eye and other organs. Furthermore, advances in deep learning have made it possible to train algorithms for the automated detection of such biomarkers. However, two key limitations of this approach are the need for large numbers of labeled images to train the algorithms, which are often not met by the typical single-centre prospective studies in the literature, and the lack of interpretability of the features learned during training. In the current study, we developed a network analysis framework to characterise retinal vasculature where geometric and topological information are exploited to increase the performance of classifiers trained on tens of OCTA images. We demonstrate our approach in two different diseases with a retinal vascular footprint: diabetic retinopathy (DR) and chronic kidney disease (CKD). Our approach enables the discovery of previously unreported retinal vascular morphological differences in DR and CKD, and demonstrate the potential of OCTA for automated disease assessment.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.